260 related articles for article (PubMed ID: 21415158)
1. Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus.
Fenske W; Wanner C; Allolio B; Drechsler C; Blouin K; Lilienthal J; Krane V;
J Am Soc Nephrol; 2011 Apr; 22(4):782-90. PubMed ID: 21415158
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy-associated plasma protein A associates with cardiovascular events in diabetic hemodialysis patients.
Kalousová M; Zima T; Krane V; März W; Wanner C; Tesař V; Drechsler C;
Atherosclerosis; 2014 Oct; 236(2):263-9. PubMed ID: 25108075
[TBL] [Abstract][Full Text] [Related]
3. Copeptin Associates with Cause-Specific Mortality in Patients with Impaired Renal Function: Results from the LURIC and the 4D Study.
Krane V; Genser B; Kleber ME; Drechsler C; März W; Delgado G; Allolio B; Wanner C; Fenske W;
Clin Chem; 2017 May; 63(5):997-1007. PubMed ID: 28280053
[TBL] [Abstract][Full Text] [Related]
4. Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.
Smaradottir MI; Ritsinger V; Gyberg V; Norhammar A; Näsman P; Mellbin LG
Diab Vasc Dis Res; 2017 Mar; 14(2):69-76. PubMed ID: 28118730
[TBL] [Abstract][Full Text] [Related]
5. Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort.
Smáradóttir MI; Catrina SB; Brismar K; Norhammar A; Gyberg V; Mellbin LG
Diab Vasc Dis Res; 2019 Jan; 16(1):22-27. PubMed ID: 30309264
[TBL] [Abstract][Full Text] [Related]
6. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
[TBL] [Abstract][Full Text] [Related]
7. Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study.
Wannamethee SG; Welsh P; Lennon L; Papacosta O; Whincup PH; Sattar N
Diabetologia; 2016 Sep; 59(9):1904-12. PubMed ID: 27312697
[TBL] [Abstract][Full Text] [Related]
8. Copeptin, IGFBP-1, and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction: a report from the DIGAMI 2 trial.
Mellbin LG; Rydén L; Brismar K; Morgenthaler NG; Ohrvik J; Catrina SB
Diabetes Care; 2010 Jul; 33(7):1604-6. PubMed ID: 20413521
[TBL] [Abstract][Full Text] [Related]
9. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.
Velho G; Ragot S; El Boustany R; Saulnier PJ; Fraty M; Mohammedi K; Fumeron F; Potier L; Marre M; Hadjadj S; Roussel R
Cardiovasc Diabetol; 2018 Aug; 17(1):110. PubMed ID: 30071874
[TBL] [Abstract][Full Text] [Related]
10. Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.
Arsenault BJ; Barter P; DeMicco DA; Bao W; Preston GM; LaRosa JC; Grundy SM; Deedwania P; Greten H; Wenger NK; Shepherd J; Waters DD; Kastelein JJ;
J Am Coll Cardiol; 2011 Jan; 57(1):63-9. PubMed ID: 21185503
[TBL] [Abstract][Full Text] [Related]
11. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31).
Riphagen IJ; Boertien WE; Alkhalaf A; Kleefstra N; Gansevoort RT; Groenier KH; van Hateren KJ; Struck J; Navis G; Bilo HJ; Bakker SJ
Diabetes Care; 2013 Oct; 36(10):3201-7. PubMed ID: 23757433
[TBL] [Abstract][Full Text] [Related]
12. Copeptin predicts coronary artery disease cardiovascular and total mortality.
Tasevska I; Enhörning S; Persson M; Nilsson PM; Melander O
Heart; 2016 Jan; 102(2):127-32. PubMed ID: 26661323
[TBL] [Abstract][Full Text] [Related]
13. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis.
Krane V; Heinrich F; Meesmann M; Olschewski M; Lilienthal J; Angermann C; Störk S; Bauersachs J; Wanner C; Frantz S;
Clin J Am Soc Nephrol; 2009 Feb; 4(2):394-400. PubMed ID: 19158371
[TBL] [Abstract][Full Text] [Related]
14. Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes.
Chan KE; Thadhani R; Lazarus JM; Hakim RM
Clin J Am Soc Nephrol; 2010 May; 5(5):856-66. PubMed ID: 20338963
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.
Krane V; Berger M; Lilienthal J; Winkler K; Schambeck C; Wanner C;
Clin J Am Soc Nephrol; 2010 May; 5(5):874-81. PubMed ID: 20185595
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
Wanner C; Krane V; März W; Olschewski M; Mann JF; Ruf G; Ritz E;
N Engl J Med; 2005 Jul; 353(3):238-48. PubMed ID: 16034009
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis.
Keller T; Wanner C; Krane V; Kraus D; Genser B; Scharnagl H; März W; Drechsler C
Am J Kidney Dis; 2018 Jun; 71(6):822-830. PubMed ID: 29310884
[TBL] [Abstract][Full Text] [Related]
18. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C
Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222
[TBL] [Abstract][Full Text] [Related]
19. Plasma copeptin and functional outcome in patients with ischemic stroke and type 2 diabetes.
Wang CB; Zong M; Lu SQ; Tian Z
J Diabetes Complications; 2016; 30(8):1532-1536. PubMed ID: 27554438
[TBL] [Abstract][Full Text] [Related]
20. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
